BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8042637)

  • 1. Emerging indications for octreotide therapy, Part 1.
    Mosdell KW; Visconti JA
    Am J Hosp Pharm; 1994 May; 51(9):1184-92. PubMed ID: 8042637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Somatostatin analog (octreotide) in clinical use: current and potential indications].
    Meier R; Dierdorf R; Gyr K
    Schweiz Med Wochenschr; 1992 Jun; 122(25):957-68. PubMed ID: 1621078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future medical prospects for Sandostatin.
    Harris AG
    Z Gastroenterol; 1990 Sep; 28 Suppl 2():55-60. PubMed ID: 1980778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin and a long-acting analogue, octreotide acetate. Relevance to dermatology.
    Camisa C
    Arch Dermatol; 1989 Mar; 125(3):407-12. PubMed ID: 2564269
    [No Abstract]   [Full Text] [Related]  

  • 5. Debut of a somatostatin analog: octreotide in review.
    Zindel LR
    Conn Med; 1989 Dec; 53(12):741-4. PubMed ID: 2558839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.
    Saslow SB; O'Brien MD; Camilleri M; von der Ohe M; Homburger HA; Klee GG; Pitot HC; Rubin J
    Am J Gastroenterol; 1997 Dec; 92(12):2250-6. PubMed ID: 9399764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide: a somatostatin analog.
    Salman K; Rose LI
    Am Fam Physician; 1989 Jun; 39(6):207-11. PubMed ID: 2543196
    [No Abstract]   [Full Text] [Related]  

  • 8. Octreotide therapy in AIDS-related, refractory diarrhea: results of a multicentre Canadian-European study. Octreotide International Multicentre AIDS-Diarrhea Study.
    Montaner JS; Harris AG
    AIDS; 1995 Feb; 9(2):209-10. PubMed ID: 7718196
    [No Abstract]   [Full Text] [Related]  

  • 9. [Somatostatin and its analogs in the treatment of gastrointestinal and liver diseases].
    Feu F; Bosch J
    Gastroenterol Hepatol; 1996 Feb; 19(2):68-77. PubMed ID: 8616683
    [No Abstract]   [Full Text] [Related]  

  • 10. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
    Plöckinger U; Quabbe HJ
    Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging indications for octreotide therapy, Part 2.
    Mosdell KW; Visconti JA
    Am J Hosp Pharm; 1994 May; 51(10):1317-30. PubMed ID: 8085570
    [No Abstract]   [Full Text] [Related]  

  • 12. Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion.
    Battershill PE; Clissold SP
    Drugs; 1989 Nov; 38(5):658-702. PubMed ID: 2689136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-centre experience with octreotide in the treatment of different hypersecretory syndromes in patients with functional gastroenteropancreatic neuroendocrine tumors.
    Berković MC; Altabas V; Herman D; Hrabar D; Goldoni V; Vizner B; Zjacić-Rotkvić V
    Coll Antropol; 2007 Jun; 31(2):531-4. PubMed ID: 17847934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential indications for octreotide in gastroenterology: summary of workshop.
    Burroughs AK; Malagelada R
    Digestion; 1993; 54 Suppl 1():59-67. PubMed ID: 8359570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current alternative in the pharmacotherapy of acromegaly: the long-acting somatostatin analogue octreotide].
    Laczi F; Magony S; Julesz J
    Orv Hetil; 2002 May; 143(19 Suppl):1062-6. PubMed ID: 12063861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative use of octreotide in gastrointestinal surgery.
    Mulvihill SJ
    Digestion; 1993; 54 Suppl 1():33-7. PubMed ID: 8359566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide treatment of carcinoid hypertensive crisis.
    Warner RR; Mani S; Profeta J; Grunstein E
    Mt Sinai J Med; 1994 Sep; 61(4):349-55. PubMed ID: 7969229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?
    Martineau P; Shwed JA; Denis R
    Am J Surg; 1996 Oct; 172(4):386-95. PubMed ID: 8873537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sandostatin in the management of nonendocrine gastrointestinal and pancreatic disorders: a preliminary study.
    Rosenberg L; Brown RA
    Can J Surg; 1991 Jun; 34(3):223-9. PubMed ID: 2054754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide in the treatment of refractory diarrhea.
    Fried M
    Digestion; 1999; 60 Suppl 2():42-6. PubMed ID: 10207230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.